Pharma & Biotech
The data were presented in detail at the recent American College of Chest Physicians (CHEST) annual meeting
IQ-AI's Imaging Biometrics at the forefront of brain tumour analysis
Sareum aims to complete at least one pre-clinical trial this year
Verona Pharma looks forward to phase III ensifentrine trials after US$200mln fundraise
Only registered members can use this feature.
© Proactive Investors 2020.
Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority. Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.